Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
B O’Brien(Unknown), Ron Goeree(Programs for Assessment of Technology in Health Research Institute), David R. Anderson(Dalhousie University)
PubMed
April 1, 1994
Cited by 106
Related Papers
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
|Blood Advances|2019|586
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
|The Lancet|2013|522
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease
|Medical Decision Making|2002|361
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease
|Medical Decision Making|2002|321